TriangleNCT02112045 · OUTCOME
Number of Participants With Neutrophil Engraftment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Up to Day 30
What was measured
Neutrophil engraftment is defined as ANC ≥ 0.5 × 10\^9/L × 3 consecutive daily assessments. The first of 3 consecutive days for which ANC ≥ 0.5 × 109/L will be recorded as the date of neutrophil engraftment. Time to neutrophil engraftment will be calculated as the time from the date of the ASCT to the date of neutrophil engraftment.
Groups in this outcome
Experimental: Granix and High Dose Melphalan (HDM)
Granix on Day -7 through Day -2. HDM intravenously (IV) on Day -2. Autologous stem cell transplantation on Day 0
Control: High Dose Melphalan (HDM)
HDM intravenously (IV) on Day -2.
| Group | Source count |
|---|---|
| Experimental: Granix and High Dose Melphalan (HDM) | 44 |
| Control: High Dose Melphalan (HDM) | 45 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Experimental: Granix and High Dose Melphalan (HDM) | 44 | Not reported | Not reported | Not reported | Not reported |
| Control: High Dose Melphalan (HDM) | 45 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 44
- group Id
- OG001
- value
- 45
- denoms
- counts
- group Id
- OG000
- value
- 44
- group Id
- OG001
- value
- 45
- units
- Participants
- description
- Neutrophil engraftment is defined as ANC ≥ 0.5 × 10\^9/L × 3 consecutive daily assessments. The first of 3 consecutive days for which ANC ≥ 0.5 × 109/L will be recorded as the date of neutrophil engraftment. Time to neutrophil engraftment will be calculated as the time from the date of the ASCT to the date of neutrophil engraftment.
- groups
- description
- Granix on Day -7 through Day -2. HDM intravenously (IV) on Day -2. Autologous stem cell transplantation on Day 0
- id
- OG000
- title
- Experimental: Granix and High Dose Melphalan (HDM)
- description
- HDM intravenously (IV) on Day -2.
- id
- OG001
- title
- Control: High Dose Melphalan (HDM)
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Up to Day 30
- title
- Number of Participants With Neutrophil Engraftment
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice